These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39007780)

  • 41. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
    Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
    Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Nomograms as Aids for Predicting Recurrence and Survival in Chordoma Patients: A Retrospective Multicenter Study in mainland China.
    Meng T; Huang R; Hu P; Yin H; Lin S; Qiao S; Wang R; Wang J; Cai Z; Huang Z; Cheng L; Song D
    Spine (Phila Pa 1976); 2021 Jan; 46(1):E37-E47. PubMed ID: 32991511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of internal mammary lymph nodes (IMLN) metastasis and disease-free survival comparison between IMLN-positive and IMLN-negative breast cancer patients: Results from Western China Clinical Cooperation Group (WCCCG) database (CONSORT).
    Wang K; Zhang X; Zheng K; Yin XD; Xing L; Zhang AJ; Shi Y; Kong LQ; Li F; Ma BL; Li H; Liu JP; Jiang J; Ren GS; Li HY
    Medicine (Baltimore); 2018 Jul; 97(28):e11296. PubMed ID: 29995764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy.
    Chen L; Huang S; Liu Q; Kong X; Su Z; Zhu M; Fang Y; Zhang L; Li X; Wang J
    Front Immunol; 2022; 13():849468. PubMed ID: 35669769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
    Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
    Technol Health Care; 2024; 32(4):2445-2461. PubMed ID: 38306071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer.
    Qin T; Zeng YD; Qin G; Xu F; Lu JB; Fang WF; Xue C; Zhan JH; Zhang XK; Zheng QF; Peng RJ; Yuan ZY; Zhang L; Wang SS
    Oncotarget; 2015 Oct; 6(32):33972-81. PubMed ID: 26378017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Establishment and validation of an ultrasound-based nomogram with risk stratification for short disease-free survival in breast cancer.
    Guo Q; Dong Z; Jiang L; Zhang L; Li Z; Wang D
    J Clin Ultrasound; 2023 Jan; 51(1):134-147. PubMed ID: 36054346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis.
    Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
    Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nomograms predicting overall survival and cancer-specific survival in metaplastic breast cancer patients.
    Shi H; Yu L; Mai J; Zhang P; Fang K
    J BUON; 2021; 26(4):1386-1397. PubMed ID: 34564996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection.
    Xiao Y; Wen X; Ying Y; Zhang X; Li L; Wang Z; Su M; Miao S
    BMC Cancer; 2024 Apr; 24(1):425. PubMed ID: 38582845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
    Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
    J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nomogram based on immune-inflammatory indicators and age-adjusted charlson comorbidity index score to predict prognosis of postoperative parotid gland carcinoma patients.
    Cheng H; Xu JH; He JQ; Wu CC; Li JF; Xu XL
    BMC Oral Health; 2024 Jun; 24(1):718. PubMed ID: 38909208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
    Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
    Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of clinical nomograms for predicting survival outcomes in young women with breast cancer.
    Lin H; Zhang F; Wang L; Zeng D
    Oncol Lett; 2019 Feb; 17(2):1505-1516. PubMed ID: 30675206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
    Resende U; Cabello C; Ramalho SOB; Zeferino LC
    BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study.
    Huang Z; Zhou X; Tong Y; Zhu L; Zhao R; Huang X
    BMC Cancer; 2021 Mar; 21(1):222. PubMed ID: 33663462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.